Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tecoma stans, also known as yellow bells or yellow trumpet bush, is a flowering perennial shrub in the Bignoniaceae family. It is widely recognized for its diverse pharmacological properties and has been traditionally used in Mexico, Central America, and the Caribbean for the management of type 2 diabetes, renal disorders, and gastrointestinal issues. Scientific investigations have demonstrated that Tecoma stans extracts possess hypoglycemic, anti-inflammatory, antioxidant, and antimetastatic activities. Its therapeutic effects are attributed to a variety of bioactive secondary metabolites, including phenylethanoid glycosides (such as verbascoside and isoverbascoside) and flavonoids (such as luteolin and apigenin). Clinical research has specifically evaluated its efficacy as part of an herbal mixture in improving metabolic profiles in diabetic patients. Additionally, its bioactive components have shown potential in inhibiting pro-inflammatory cytokines and markers of oxidative stress in arthritic models.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tecoma stans.